These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29730376)

  • 1. Restenosis in Magmaris Stents Due to Significant Collapse.
    Yang H; Zhang F; Qian J; Chen J; Ge J
    JACC Cardiovasc Interv; 2018 May; 11(10):e77-e78. PubMed ID: 29730376
    [No Abstract]   [Full Text] [Related]  

  • 2. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
    Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
    Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
    [No Abstract]   [Full Text] [Related]  

  • 3. Early collapse causing stenosis in a resorbable magnesium scaffold.
    Marynissen T; McCutcheon K; Bennett J
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):310-312. PubMed ID: 30019823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of In-Stent Restenosis: When the Stent Is No Longer There.
    Antuña P; Cuesta J; García-Guimaraes M; Bastante T; De Rueda C; Rivero F; Alfonso F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):e53-e55. PubMed ID: 31883713
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery.
    Gargiulo G; Longo G; Capodanno D; Francaviglia B; Capranzano P; Tamburino C
    JACC Cardiovasc Interv; 2015 May; 8(6):e95-e97. PubMed ID: 25999117
    [No Abstract]   [Full Text] [Related]  

  • 6. Restenosis in a Collapsed Magnesium Bioresorbable Scaffold.
    Barkholt TØ; Neghabat O; Terkelsen CJ; Christiansen EH; Holm NR
    Circ Cardiovasc Interv; 2017 Oct; 10(10):. PubMed ID: 29042399
    [No Abstract]   [Full Text] [Related]  

  • 7. In-Stent Restenosis: Is the Future Bioresorbable?
    Claessen BE; Feldman DN
    JACC Cardiovasc Interv; 2024 Aug; 17(15):1837-1839. PubMed ID: 39142759
    [No Abstract]   [Full Text] [Related]  

  • 8. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioresorbable Scaffold Failure Due to Chronic Recoil in a Myocardial Bridge.
    Giavarini A; Longo G; Chen J; Rodríguez R; Di Mario C
    JACC Cardiovasc Interv; 2016 Mar; 9(6):e49-51. PubMed ID: 26803423
    [No Abstract]   [Full Text] [Related]  

  • 10. Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
    Azzalini L; Al-Hawwas M; L'Allier PL
    EuroIntervention; 2015 May; 11(1):e1-2. PubMed ID: 25982486
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
    Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
    EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioresorbable scaffolds for the treatment of in-stent restenosis.
    Dörr O; Liebetrau C; Wiebe J; Hecker F; Rixe J; Möllmann H; Hamm C; Nef H
    Heart Vessels; 2015 Mar; 30(2):265-9. PubMed ID: 24390727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioresorbable vascular scaffolds: the shape of things to come?
    Safian RD
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):472-3. PubMed ID: 22431381
    [No Abstract]   [Full Text] [Related]  

  • 14. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
    Granata F; Moscarella E; Varricchio A
    Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
    [No Abstract]   [Full Text] [Related]  

  • 15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.
    Versaci F; Vizzari G; Prati F; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2020 May; 21(5):398-400. PubMed ID: 32243342
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence, Clinical Presentation, and Predictors of Clinical Restenosis in Coronary Bioresorbable Scaffolds.
    Polimeni A; Weissner M; Schochlow K; Ullrich H; Indolfi C; Dijkstra J; Anadol R; Münzel T; Gori T
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1819-1827. PubMed ID: 28935073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 19. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 20. First experience of drug-coated balloons for treatment of bioresorbable vascular scaffold restenosis.
    Elwany M; Latini RA; Di Palma G; Orrego PS; Cortese B
    Cardiovasc Revasc Med; 2017; 18(7):482-486. PubMed ID: 28385555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.